Combined therapy with methotrexate nanoconjugate and dendritic cells with downregulated il-10r expression modulates the tumor microenvironment and enhances the systemic anti-tumor immune response in mc38 murine colon carcinoma

HIGHLIGHTS

  • who: Agnieszka Szczygieu0142 and colleagues from the Transplantation Unit (IRCCS), Italy Vilnius University, Lithuania have published the Article: Combined therapy with methotrexate nanoconjugate and dendritic cells with downregulated IL-10R expression modulates the tumor microenvironment and enhances the systemic anti-tumor immune response in MC38 murine colon carcinoma, in the Journal: (JOURNAL)
  • what: Although various populations of immune cells present in the tumor were assessed during the analysis, the authors decided to discuss selected results that indicate the impact of applied therapy on the changes in the landscape of TME. Taking into consideration the previous . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?